Brian VanScoy
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
- Pharmacology 36
- Antibiotics Pharmacokinetics and Efficacy 35
-
- Antibiotic Resistance in Bacteria 35
- Co-authors
- Paul G. Ambrose (34 shared papers)Sujata M. Bhavnani (25 shared papers)George L. Drusano (12 shared papers)Arnold Louie (11 shared papers)David R. Andes (7 shared papers)Alexander J. Lepak (7 shared papers)Miao Zhao (4 shared papers)Ronald N. Jones (6 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (36 papers)Open Forum Infectious Diseases (8 papers)Journal of Antimicrobial Chemotherapy (1 paper)Clinical Microbiology and Infection (1 paper)Current Opinion in Pharmacology (1 paper)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Brian VanScoy
49 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 77
- Molecular Medicine 734
- Applied Microbiology and Biotechnology 200
- Pharmacology 710
- Epidemiology 533
- Clinical Biochemistry 81
Countries citing papers authored by Brian VanScoy
This map shows the geographic impact of Brian VanScoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian VanScoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian VanScoy more than expected).
Fields of papers citing papers by Brian VanScoy
This network shows the impact of papers produced by Brian VanScoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian VanScoy. The network helps show where Brian VanScoy may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian VanScoy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 95 | |
| 2 | 2017 | 88 | |
| 3 | 2011 | 69 | |
| 4 | 2013 | 62 | |
| 5 | 2018 | 54 | |
| 6 | 2017 | 52 | |
| 7 | 2015 | 49 | |
| 8 | 2011 | 47 | |
| 9 | 2011 | 47 | |
| 10 | 2016 | 46 | |
| 11 | 2011 | 39 | |
| 12 | 2014 | 36 | |
| 13 | 2013 | 35 | |
| 14 | 2008 | 29 | |
| 15 | 2011 | 28 | |
| 16 | 2016 | 25 | |
| 17 | 2018 | 25 | |
| 18 | 2019 | 23 | |
| 19 | 2017 | 22 | |
| 20 | 2020 | 18 |
About Brian VanScoy
Brian VanScoy is a scholar working on Pharmacology, Molecular Medicine, Epidemiology, Infectious Diseases and Molecular Biology, having authored 49 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (35 papers), Antibiotic Resistance in Bacteria (35 papers), Pneumonia and Respiratory Infections (11 papers), Urinary Tract Infections Management (5 papers), Bacillus and Francisella bacterial research (5 papers), Antifungal resistance and susceptibility (5 papers), Antibiotic Use and Resistance (5 papers) and Bacterial Identification and Susceptibility Testing (4 papers). The work is most often cited by research in Molecular Medicine (734 citations), Applied Microbiology and Biotechnology (200 citations), Pharmacology (710 citations), Epidemiology (533 citations) and Clinical Biochemistry (81 citations). Brian VanScoy has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Paul G. Ambrose, Sujata M. Bhavnani, George L. Drusano, Arnold Louie, David R. Andes, Alexander J. Lepak, Miao Zhao, Ronald N. Jones, Jennifer McCauley and Lawrence V. Friedrich. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Open Forum Infectious Diseases, Journal of Antimicrobial Chemotherapy, Clinical Microbiology and Infection and Current Opinion in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.